Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGIN

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Pharma stocks buck the trend
Thu, 12 Apr 11:30 am

Indian stock markets continued to trade in the green during the last two hours of trade on the back of sustained buying across index heavyweights. All sectoral indices are trading in the green except pharmaceutical stocks.

The BSE-Sensex is trading down up 132 points and NSE-Nifty is trading up by 45 points. BSE Mid Cap and BSE Small Cap indices are trading up by 1.2% each. The rupee is trading at 51.38 to the US dollar.

Automobile stocks are trading in the green led by Force Motors and Eicher Motors. According to a leading financial daily, Mahindra & Mahindra is developing a full hybrid vehicle for the Indian markets. It may be noted here that hybrid vehicles are vehicles that have conventional internal combustion engines with one or more electric motors that cause lesser pollution than the normal ones. These hybrids tend to be more expensive and have a niche customer base. A team of 14 people is working towards this at M&M's newly established research and development (R&D) centre in Oragadam in Chennai. The project is likely to cost Rs 3 bn and the hybrid vehicle by M&M is expected to hit the markets in next 3 years or so.

Energy stocks are trading strong led by Gujarat Gas and Essar Oil. According to a leading financial daily, Hindustan Petroleum Corporation Limited (HPCL) has entered into a pact with Force Motors to supply engine oil to the automobile company. As per the agreement, HPCL will provide engine oil for the entire range of Force Motors' automotive aggregates like engine, gearbox and axles. HPCL's HP Force Genuine Oils will be distributed through its strong network of distributors throughout India. Force will be using this across its range of vehicles including light commercial, multi-utility, agricultural and personal vehicles.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

View all commentaries | Archives

Read the latest Market Commentary


Equitymaster requests your view! Post a comment on "Pharma stocks buck the trend". Click here!

  
ABOUT EQUITYMASTER

Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.

PREMIUM PRODUCTS
QUICK LINKS
POPULAR TOPICS
TRENDING TOPICS
FREE NEWSLETTERS
EQUITYMASTER SUPPORTS
  • HelpYourNGO
  • You Tube
  • Linkedin
  • Twitter
  • Telegram
  • Google Play

Copyright © Equitymaster Agora Research Private Limited.

Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap

Phone +91-9136015013

Equitymaster Agora Research Private Limited (Research Analyst)
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Email: info@equitymaster.com. Website: www.equitymaster.com.
CIN:U74999MH2007PTC175407

Name of the Compliance & Grievance Officer: Ms Sonal Ramachandran
Telephone: +91-22-61434003 | Email: compliance@equitymaster.com

LEGAL DISCLAIMER:
Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

Equitymaster Agora Research Private Limited (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.